1. StClair EG, McCutcheon IE. Skull tumors. In: Winn H, editors. Youmans and Winn neurological surgery. Elsevier; 2022. p. 1444e1-e26.
2. Yang L, Wu H, Lu J, Teng L. Prevalence of different forms and involved bones of craniofacial fibrous dysplasia. J Craniofac Surg 2017;28:21-5.
3. Rahman AM, Madge SN, Billing K, Anderson PJ, Leibovitch I, Selva D, et al. Craniofacial fibrous dysplasia: clinical characteristics and long-term outcomes. Eye (Lond) 2009;23:2175-81.
4. Ricalde P, Magliocca KR, Lee JS. Craniofacial fibrous dysplasia. Oral Maxillofac Surg Clin North Am 2012;24:427-41.
5. Ippolito E, Bray EW, Corsi A, De Maio F, Exner UG, Robey PG, et al. Natural history and treatment of fibrous dysplasia of bone: a multicenter clinicopathologic study promoted by the European Pediatric Orthopaedic Society. J Pediatr Orthop B 2003;12:155-77.
6. Byers PD, Jones AN. Leontiasis ossea. Br J Surg 1969;56:262-7.
7. Chapurlat RD, Orcel P. Fibrous dysplasia of bone and McCune-Albright syndrome. Best Pract Res Clin Rheumatol 2008;22:55-69.
8. Weinstein LS. G(s)alpha mutations in fibrous dysplasia and McCune-Albright syndrome. J Bone Miner Res 2006;21 (Suppl 2):P120-4.
9. Lumbroso S, Paris F, Sultan C. McCune-Albright syndrome: molecular genetics. J Pediatr Endocrinol Metab 2002;15 (Suppl 3):875-82.
10. Weinstein LS, Yu S, Warner DR, Liu J. Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting. Endocr Rev 2001;22:675-705.
11. Happle R. The McCune-Albright syndrome: a lethal gene surviving by mosaicism. Clin Genet 1986;29:321-4.
12. Ricalde P, Horswell BB. Craniofacial fibrous dysplasia of the fronto-orbital region: a case series and literature review. J Oral Maxillofac Surg 2001;59:157-68.
14. Riminucci M, Kuznetsov SA, Cherman N, Corsi A, Bianco P, Gehron Robey P. Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression. Bone 2003;33:434-42.
15. Riminucci M, Fisher LW, Shenker A, Spiegel AM, Bianco P, Gehron Robey P. Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation. Am J Pathol 1997;151:1587-600.
16. Collins MT, Chebli C, Jones J, Kushner H, Consugar M, Rinaldo P, et al. Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia. J Bone Miner Res 2001;16:806-13.
17. Hart ES, Kelly MH, Brillante B, Chen CC, Ziran N, Lee JS, et al. Onset, progression, and plateau of skeletal lesions in fibrous dysplasia and the relationship to functional outcome. J Bone Miner Res 2007;22:1468-74.
18. Robey PG, Kuznetsov S, Riminucci M, Bianco P. The role of stem cells in fibrous dysplasia of bone and the Mccune-Albright syndrome. Pediatr Endocrinol Rev 2007;4 (Suppl 4):386-94.
20. Bousson V, Rey-Jouvin C, Laredo JD, Le Merrer M, Martin-Duverneuil N, Feydy A, et al. Fibrous dysplasia and McCune-Albright syndrome: imaging for positive and differential diagnoses, prognosis, and follow-up guidelines. Eur J Radiol 2014;83:1828-42.
22. Lee JS, FitzGibbon E, Butman JA, Dufresne CR, Kushner H, Wientroub S, et al. Normal vision despite narrowing of the optic canal in fibrous dysplasia. N Engl J Med 2002;347:1670-6.
24. Chanson P, Salenave S, Orcel P. McCune-Albright syndrome in adulthood. Pediatr Endocrinol Rev 2007;4 (Suppl 4):453-62.
26. Yabut SM Jr, Kenan S, Sissons HA, Lewis MM. Malignant transformation of fibrous dysplasia: a case report and review of the literature. Clin Orthop Relat Res 1988;(228):281-9.
27. Ozcan I, Unsal G, Koca RB, Orhan K. Craniofacial fibrous dysplasia involvements of Mccune-Albright syndrome: a review with an additional case. Curr Med Imaging 2021;17:864-70.
29. DiCaprio MR, Enneking WF. Fibrous dysplasia: pathophysiology, evaluation, and treatment. J Bone Joint Surg Am 2005;87:1848-64.
31. Chapurlat RD, Delmas PD, Liens D, Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. J Bone Miner Res 1997;12:1746-52.
32. Liens D, Delmas PD, Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet 1994;343:953-4.
33. Plotkin H, Rauch F, Zeitlin L, Munns C, Travers R, Glorieux FH. Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. J Clin Endocrinol Metab 2003;88:4569-75.
35. Chapurlat RD. Medical therapy in adults with fibrous dysplasia of bone. J Bone Miner Res 2006;21 (Suppl 2):P114-9.
37. Lisle DA, Monsour PA, Maskiell CD. Imaging of craniofacial fibrous dysplasia. J Med Imaging Radiat Oncol 2008;52:325-32.
40. Becelli R, Perugini M, Cerulli G, Carboni A, Renzi G. Surgical treatment of fibrous dysplasia of the cranio-maxillo-facial area: review of the literature and personal experience form 1984 to 1999. Minerva Stomatol 2002;51:293-300.
42. Sachs SA. Two case studies of fibrous dysplasia encompassing three decades: a clinical pathologic review. Oral Maxillofac Surg Clin North Am 1997;9:731-49.
44. Kang SJ, Oh MJ, Jeon SP. A novel and easy approach for contouring surgery in patients with craniofacial fibrous dysplasia. J Craniofac Surg 2015;26:1977-8.
46. Tessaris D, Boyce AM, Zacharin M, Matarazzo P, Lala R, De Sanctis L, et al. Growth hormone-insulin-like growth factor 1 axis hyperactivity on bone fibrous dysplasia in McCune-Albright Syndrome. Clin Endocrinol (Oxf) 2018;89:56-64.
47. Chen YR, Noordhoff MS. Treatment of craniomaxillofacial fibrous dysplasia: how early and how extensive? Plast Reconstr Surg 1990;86:835-44.
50. Cho SW, Choi WS, Kim BK. A multimodal approach to huge fibrous dysplasia with ocular symptoms using a navigation system and endoscope. J Craniofac Surg 2022;33:e342-5.
51. Choi JW, Lee SW, Koh KS. Correction of proptosis and zygomaticomaxillary asymmetry using orbital wall decompression and zygoma reduction in craniofacial fibrous dysplasia. J Craniofac Surg 2009;20:326-30.
52. Lee YH, Hwang K. Decortication of fibrous dysplasia of the maxillary sinus. J Craniofac Surg 2011;22:139-41.
53. Kim JH, Kim J, Cho SW, Kim BK. Core extirpation and zygoma reduction: a new surgical approach for fibrous dysplasia of zygomaticomaxillary region. J Craniofac Surg 2022;33:1174-7.
54. Chattopadhyay A, Jain S, Sharma A. Craniofacial fibrous dysplasia. J Clin Rheumatol 2020;26:e214.
55. Hu AC, Lee CJ, Hsu FP, Vyas RM. Extensive polyostotic craniofacial fibrous dysplasia with optic nerve impingement. J Craniofac Surg 2021;32:e435-7.
57. Papadopoulos MC, Casey AT, Powell M. Craniofacial fibrous dysplasia complicated by acute, reversible visual loss: report of two cases. Br J Neurosurg 1998;12:159-61.
58. Cutler CM, Lee JS, Butman JA, FitzGibbon EJ, Kelly MH, Brillante BA, et al. Long-term outcome of optic nerve encasement and optic nerve decompression in patients with fibrous dysplasia: risk factors for blindness and safety of observation. Neurosurgery 2006;59:1011-8.
60. Yeow VK, Chen YR. Orthognathic surgery in craniomaxillofacial fibrous dysplasia. J Craniofac Surg 1999;10:155-9.
61. Cheung LK, Samman N, Pang M, Tideman H. Titanium miniplate fixation for osteotomies in facial fibrous dysplasia: a histologic study of the screw/bone interface. Int J Oral Maxillofac Surg 1995;24:401-5.
62. Meiselman F. Fibrous dysplasia of the facial bones: combined recontouring and orthognathic surgical treatment. Oral Maxillofac Surg Clin North Am 1997;9:721-9.